Teladoc Health, Inc. (FRA:4LL)
6.48
+0.09 (1.39%)
At close: Nov 28, 2025
Teladoc Health Revenue
Teladoc Health had revenue of $626.44M USD in the quarter ending September 30, 2025, a decrease of -2.20%. This brings the company's revenue in the last twelve months to $2.53B, down -2.37% year-over-year. In the year 2024, Teladoc Health had annual revenue of $2.57B, down -1.26%.
Revenue (ttm)
$2.53B
Revenue Growth
-2.37%
P/S Ratio
0.53
Revenue / Employee
$459.67K
Employees
5,500
Market Cap
1.14B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.57B | -32.84M | -1.26% |
| Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
| Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
| Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
| Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
| Dec 31, 2019 | 553.31M | 135.40M | 32.40% |
| Dec 31, 2018 | 417.91M | 184.63M | 79.14% |
| Dec 31, 2017 | 233.28M | 110.12M | 89.42% |
| Dec 31, 2016 | 123.16M | 45.77M | 59.15% |
| Dec 31, 2015 | 77.38M | 33.86M | 77.78% |
| Dec 31, 2014 | 43.53M | 23.62M | 118.67% |
| Dec 31, 2013 | 19.91M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.87B |
| Siemens Healthineers AG | 23.38B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.27B |
| Fresenius Medical Care AG | 19.64B |
| Sartorius Aktiengesellschaft | 3.52B |
| Redcare Pharmacy NV | 2.82B |
| Fielmann Group AG | 2.42B |